Multimodal Model Predicts Recurrence (NCT06690268) | Clinical Trial Compass
CompletedNot Applicable
Multimodal Model Predicts Recurrence
China93 participantsStarted 2022-01-01
Plain-language summary
This study focuses on developing an advanced model that combines clinical information, imaging, and pathology data to predict the likelihood of cancer returning after surgery in patients with locally advanced gastric cancer. By using artificial intelligence (AI), this model analyzes various data sources to create a more accurate prediction of recurrence risk, which can help doctors, patients, and families better understand the chances of recurrence. This AI-driven approach allows healthcare providers to make more informed decisions about personalized follow-up care and potential additional treatments to improve patient outcomes.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
\*\*Inclusion Criteria:\*\*
* Patients diagnosed with locally advanced gastric cancer (Stage II or III).
* Patients who have undergone surgical resection for gastric cancer.
* Patients with complete clinical, imaging, and pathology data available for analysis.
* Age 18 years or older.
* Patients who provide informed consent to participate in the study.
\*\*Exclusion Criteria:\*\*
* Patients with distant metastasis (Stage IV) at the time of diagnosis.
* Patients with incomplete or missing clinical, imaging, or pathology data.
* Patients who have received prior treatment for gastric cancer other than surgical resection.
* Patients with other concurrent malignancies.
* Patients who are unable or unwilling to comply with the study follow-up requirements.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Prediction accuracy of postoperative recurrence in locally advanced gastric cancer